Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2005
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1527047A1 3-z- 1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-me thyl-amino)-anilino)-1-phenyl-methylene -6-methoxycarbonyl-2 -indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
05/04/2005EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1526863A2 Using heat shock proteins to increase immune response
05/04/2005EP1526862A1 Simmondsin for use as an angiogenesis inhibitor
05/04/2005EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
05/04/2005EP1526856A1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
05/04/2005EP1526854A1 4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases
05/04/2005EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
05/04/2005EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound
05/04/2005EP1526846A2 Gelatin capsule exhibiting reduced cross-linking
05/04/2005EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
05/04/2005EP1526844A2 Pellicle-resistant gelatin capsule
05/04/2005EP1446399B1 Piperazine derivatives having sst1 antagonistic activity
05/04/2005EP1404663B1 Eurotinone and derivatives thereof, method for the production and use of the same
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1377164A4 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
05/04/2005EP1362048B1 Triazolo compounds as mmp inhibitors
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1315520B1 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
05/04/2005EP1297121B1 Purging of cells using viruses
05/04/2005EP1296984B1 Pharmaceutical composition comprising a farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
05/04/2005EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
05/04/2005EP1220676B1 Prevention of colorectal cancer
05/04/2005EP1218395B1 Antisense modulation of x-linked inhibitor of apoptosis expression
05/04/2005EP1206256B1 Combination therapy using pentafluorobenzenesulfonamide and platin compound
05/04/2005EP1140017B9 Water-insoluble drug delivery system
05/04/2005EP1139752B1 Methods and compositions for treatment of cell proliferative disorders
05/04/2005EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/04/2005EP1119567B1 Quinazoline derivatives
05/04/2005EP1109812B1 Pyrrolobenzodiazepines
05/04/2005EP1028758B1 Radioactive compositions for the treatment of prostate tumors
05/04/2005EP0994730B1 LABELLED FACTOR XIIIa SUBSTRATES
05/04/2005EP0941227B9 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
05/04/2005EP0835266B1 Modified/chimeric superantigens and their use
05/04/2005EP0815099B1 Tricyclic amide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/04/2005CN1612935A Expression vectors encoding epitopes of target-associated antigens and methods for their design
05/04/2005CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours
05/04/2005CN1612893A VEGF peptides and their use for inhibiting angiogenesis
05/04/2005CN1612890A Novel chimeric tnf ligands
05/04/2005CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612863A Deuterated substituted pyrazolylbenzylsulfonamides pharmaceutical compositions containing them and use thereof
05/04/2005CN1612857A Geranyl compounds
05/04/2005CN1612856A 1, 3-diarylprop-2-en-1-ones, compositions containing same and use thereof
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612750A TACI-immunoglobulin fusion proteins
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612743A Herbal composition phy906 and its use in chemotheraphy
05/04/2005CN1612739A Method for treating or preventing inflammatory diseases
05/04/2005CN1612738A Combination therapy comprising ZD6474 and a taxane
05/04/2005CN1612737A Platinum derivative pharmaceutical formulations
05/04/2005CN1612733A Benzimidazoles useful as protein kinase inhibitors
05/04/2005CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
05/04/2005CN1612729A 2-aryl-propionic acid and medicine composition containing same
05/04/2005CN1612728A Method and pharmaceutical preparations for reducing the activity of cells
05/04/2005CN1612724A Vascular occlusion solid-phase agent with immobilised platelet binding agent
05/04/2005CN1611605A Method for producing human leukemia inhibitory factor using transgenic plant
05/04/2005CN1611603A Novel DNA fragment and its inhibition from tumour
05/04/2005CN1611512A Poly peptide for therapeutic antitumour vaccive
05/04/2005CN1611505A Novel 9-nitro campotothecin crystal form and medicinal composition
05/04/2005CN1611500A 3-aryl-Beta-carboline-1-ketone compound, and its preparing method and use
05/04/2005CN1611264A CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour
05/04/2005CN1611260A Combined medicine of adefovir dipivoxil
05/04/2005CN1611254A American ginseng fruit, and its medicinal composition and pharmaceutical use
05/04/2005CN1611243A Gastrodia-pseudo-ginseng micro-powder composition
05/04/2005CN1611221A Injection liquid containing alprostadic and its production process
05/04/2005CN1611213A Novel 13 uses of neoarsphenamine
05/04/2005CN1200002C Human melanin tumour monoclonal antibody, and its preparing method and use
05/04/2005CN1200000C Cyclie somatostatin analogs
05/04/2005CN1199998C Human protein with suppression to cance cell growth and its coding sequence
05/04/2005CN1199996C New human protein having cancer cell growth in hibiting function and its coding sequence
05/04/2005CN1199995C New Human protein having cancer inhibiting function and its coding sequence
05/04/2005CN1199994C New human protein with cancer cell growth inhibiting function and its coding sequence
05/04/2005CN1199991C Cockroach polypeptide extracted from cockroach and extraction method thereof
05/04/2005CN1199990C Endothelial cell growth resisting engineered protein
05/04/2005CN1199966C Process for preparing VE-succinate
05/04/2005CN1199962C Anti-tumor medicine and use thereof
05/04/2005CN1199956C Oxadiazole derivs. having anticancer effects
05/04/2005CN1199946C Specific indole compound and its preparation and use in treating and preventing cancers
05/04/2005CN1199931C Naphthalene alizarine derivatives, preparing method and use thereof
05/04/2005CN1199691C Process for preparing acellular short corynebacteria prepaation
05/04/2005CN1199672C Chinese medicine for preventing and curing cancer
05/04/2005CN1199665C Discorea nipponica and new use of its active component
05/04/2005CN1199657C Anticancer ointment
05/04/2005CN1199653C Application of basil polysaccharide for preparing medicine for curing tumour transferring
05/04/2005CN1199644C Medicine for treatment of accidental extravasation of anthryracyclines
05/04/2005CN1199636C Use of 15-deoxysperguallin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
05/03/2005US6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
05/03/2005US6888014 Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
05/03/2005US6887997 Tricyclic analogues of guanosine, a nucleobase for treating tumor
05/03/2005US6887996 Compounds and their use
05/03/2005US6887975 Serpentine protein for use in the treatment of cancer
05/03/2005US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
05/03/2005US6887905 Treatment of depression or generalized anxiety disorder
05/03/2005US6887904 Substituted arylcycloalkanes, compositions containing them and use thereof
1 ... 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 ... 2211